BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Treatment
13 results:

  • 1. Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome.
    Minz AP; Mohapatra D; Dutta M; Sethi M; Parida D; Mohapatra AP; Mishra S; Kar S; Sasmal PK; Senapati S
    Cancer Immunol Immunother; 2023 Dec; 72(12):4261-4278. PubMed ID: 37926727
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Interplay between MAP kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer.
    Kumar S; Singh SK; Srivastava P; Suresh S; Rana B; Rana A
    Adv Cancer Res; 2023; 159():113-143. PubMed ID: 37268394
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer.
    Davidson C; Taggart D; Sims AH; Lonergan DW; Canel M; Serrels A
    Br J Cancer; 2022 Nov; 127(10):1893-1905. PubMed ID: 36138073
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Implications of PD-1, Tim-3, and TIGIT Expression for cancer Immunity and pancreatic cancer Prognosis.
    Nakayama C; Tanoue K; Idichi T; Shimomura H; Kita Y; Hozaka Y; Shinden Y; Matsushita D; Nakajo A; Arigami T; Mataki Y; Kurahara H; Ohtsuka T
    Anticancer Res; 2022 Jul; 42(7):3373-3380. PubMed ID: 35790289
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PD-L1 and PD-L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules.
    Zhang Y; Chen X; Mo S; Ma H; Lu Z; Yu S; Chen J
    J Pathol Clin Res; 2022 May; 8(3):257-267. PubMed ID: 35037417
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. treatment outcomes of advanced digestive well-differentiated grade 3 NETs.
    de Mestier L; Lamarca A; Hernando J; Zandee W; Alonso-Gordoa T; Perrier M; Walenkamp AM; Chakrabarty B; Landolfi S; Van Velthuysen MF; Kats-Ugurlu G; Caminoa A; Ronot M; Manoharan P; Garcia-Alvarez A; Brabander T; García Gómez-Muriel MI; Cadiot G; Couvelard A; Capdevila J; Pavel ME; Cros J
    Endocr Relat Cancer; 2021 Jun; 28(8):549-561. PubMed ID: 34061764
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Advanced breast cancer with cachexia: A case report.
    Liu N; Li S; Jia J; Qiao Y; Li Y
    Medicine (Baltimore); 2021 Jan; 100(4):e24397. PubMed ID: 33530236
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy.
    Hsu CC; Liu KH; Chang PH; Chen PT; Hung CY; Hsueh SW; Yeh KY; Chen YY; Lu CH; Hung YS; Chou WC
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1694-1703. PubMed ID: 31711261
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
    Weiss GJ; Waypa J; Blaydorn L; Coats J; McGahey K; Sangal A; Niu J; Lynch CA; Farley JH; Khemka V
    Br J Cancer; 2017 Jun; 117(1):33-40. PubMed ID: 28588322
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of gemcitabine efficacy after the FOLFIRINOX regimen in patients with advanced pancreatic adenocarcinoma.
    Gilabert M; Chanez B; Rho YS; Giovanini M; Turrini O; Batist G; Kavan P; Raoul JL
    Medicine (Baltimore); 2017 Apr; 96(16):e6544. PubMed ID: 28422841
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced pancreatic Adenocarcinoma.
    Vienot A; Beinse G; Louvet C; de Mestier L; Meurisse A; Fein F; Heyd B; Cleau D; d'Engremont C; Dupont-Gossart AC; Lakkis Z; Tournigand C; Bouché O; Rousseau B; Neuzillet C; Bonnetain F; Borg C; Vernerey D
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383673
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].
    Dreyer C; Afchain P; Trouilloud I; André T
    Bull Cancer; 2016; 103(7-8):643-50. PubMed ID: 27345450
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Vertebral Compression Fracture Related to pancreatic cancer With Osteoblastic Metastasis: A Case Report and Literature Review.
    Chih YP; Wu WT; Lin CL; Jou HJ; Huang YH; Chen LC; Chou LW
    Medicine (Baltimore); 2016 Feb; 95(5):e2670. PubMed ID: 26844499
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.